These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 8400321)
1. Differential expression of steroid receptors, hsp27, and pS2 in a series of drug resistant human breast tumor cell lines derived following exposure to antitumor drugs or to fractionated X-irradiation. Whelan RD; Hill BT Breast Cancer Res Treat; 1993; 26(1):23-39. PubMed ID: 8400321 [TBL] [Abstract][Full Text] [Related]
2. Differential increases in glutathione S-transferase activities in a range of multidrug-resistant human tumor cell lines. Whelan RD; Hosking LK; Townsend AJ; Cowan KH; Hill BT Cancer Commun; 1989; 1(6):359-65. PubMed ID: 2702041 [TBL] [Abstract][Full Text] [Related]
3. Identification of a distinctive P-glycoprotein-mediated resistance phenotype in human ovarian carcinoma cells after their in vitro exposure to fractionated X-irradiation. Hill BT; Whelan RD; Hurst HC; McClean S Cancer; 1994 Jun; 73(12):2990-9. PubMed ID: 7911070 [TBL] [Abstract][Full Text] [Related]
4. Multiple mechanisms of resistance in a series of human testicular teratoma cell lines selected for increasing resistance to etoposide. Hosking LK; Whelan RD; Shellard SA; Davies SL; Hickson ID; Danks MK; Hill BT Int J Cancer; 1994 Apr; 57(2):259-67. PubMed ID: 7908897 [TBL] [Abstract][Full Text] [Related]
5. Characterization of four doxorubicin adapted human breast cancer cell lines with respect to chemotherapeutic drug sensitivity, drug resistance associated membrane proteins and glutathione transferases. de la Torre M; Hao XY; Larsson R; Nygren P; Tsuruo T; Mannervik B; Bergh J Anticancer Res; 1993; 13(5A):1425-30. PubMed ID: 7902062 [TBL] [Abstract][Full Text] [Related]
6. Differential patterns of anti-tumour drug responses and mechanisms of resistance in a series of independently-derived VP-16-resistant human tumour cell lines. Lock RB; Hill BT Int J Cancer; 1988 Sep; 42(3):373-81. PubMed ID: 3417366 [TBL] [Abstract][Full Text] [Related]
7. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1. Lykkesfeldt AE; Madsen MW; Briand P Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264 [TBL] [Abstract][Full Text] [Related]
8. Modulatory effect of tamoxifen and ICI 182,780 on adriamycin resistance in MCF-7 human breast-cancer cells. De Vincenzo R; Scambia G; Benedetti Panici P; Fattorossi A; Bonanno G; Ferlini C; Isola G; Pernisco S; Mancuso S Int J Cancer; 1996 Nov; 68(3):340-8. PubMed ID: 8903476 [TBL] [Abstract][Full Text] [Related]
9. Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifen. Herman ME; Katzenellenbogen BS J Steroid Biochem Mol Biol; 1996 Oct; 59(2):121-34. PubMed ID: 9010327 [TBL] [Abstract][Full Text] [Related]
10. A multidrug-resistant MCF-7 human breast cancer cell line which exhibits cross-resistance to antiestrogens and hormone-independent tumor growth in vivo. Vickers PJ; Dickson RB; Shoemaker R; Cowan KH Mol Endocrinol; 1988 Oct; 2(10):886-92. PubMed ID: 3185565 [TBL] [Abstract][Full Text] [Related]
11. Differential cytotoxic effects of docetaxel in a range of mammalian tumor cell lines and certain drug resistant sublines in vitro. Hill BT; Whelan RD; Shellard SA; McClean S; Hosking LK Invest New Drugs; 1994; 12(3):169-82. PubMed ID: 7896535 [TBL] [Abstract][Full Text] [Related]
12. Long-term hydroxytamoxifen treatment of an MCF-7-derived breast cancer cell line irreversibly inhibits the expression of estrogenic genes through chromatin remodeling. Badia E; Duchesne MJ; Semlali A; Fuentes M; Giamarchi C; Richard-Foy H; Nicolas JC; Pons M Cancer Res; 2000 Aug; 60(15):4130-8. PubMed ID: 10945620 [TBL] [Abstract][Full Text] [Related]
13. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity. David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791 [TBL] [Abstract][Full Text] [Related]
14. Relationship between expression of P-glycoprotein and efficacy of trifluoperazine in multidrug-resistant cells. Ganapathi R; Kuo T; Teeter L; Grabowski D; Ford J Mol Pharmacol; 1991 Jan; 39(1):1-8. PubMed ID: 1670962 [TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance. Ogretmen B; McCauley MD; Safa AR Biochemistry; 1998 Aug; 37(33):11679-91. PubMed ID: 9709006 [TBL] [Abstract][Full Text] [Related]
16. Anti-proliferative and anti-estrogenic effects of ICI 164,384 and ICI 182,780 in 4-OH-tamoxifen-resistant human breast-cancer cells. Coopman P; Garcia M; BrĂ¼nner N; Derocq D; Clarke R; Rochefort H Int J Cancer; 1994 Jan; 56(2):295-300. PubMed ID: 8314314 [TBL] [Abstract][Full Text] [Related]
17. [Status of estrogen receptor affects the drug sensitivity of drug-resistant MCF-7/Adr human breast cancer cells to droloxifene and Adriamycin]. Gao HD; Sun JZ; Bi DS; Ma R Ai Zheng; 2003 Apr; 22(4):376-9. PubMed ID: 12703992 [TBL] [Abstract][Full Text] [Related]
18. Resistance of human breast-cancer cells to the pure steroidal anti-estrogen ICI 182,780 is not associated with a general loss of estrogen-receptor expression or lack of estrogen responsiveness. Larsen SS; Madsen MW; Jensen BL; Lykkesfeldt AE Int J Cancer; 1997 Sep; 72(6):1129-36. PubMed ID: 9378550 [TBL] [Abstract][Full Text] [Related]
19. Dominant expression of multiple drug resistance after in vitro X-irradiation exposure in intraspecific Chinese hamster ovary hybrid cells. McClean S; Hosking LK; Hill BT J Natl Cancer Inst; 1993 Jan; 85(1):48-53. PubMed ID: 8093217 [TBL] [Abstract][Full Text] [Related]
20. Role of differential drug uptake, efflux, and binding of etoposide in sensitive and resistant human tumor cell lines: implications for the mechanisms of drug resistance. Politi PM; Sinha BK Mol Pharmacol; 1989 Mar; 35(3):271-8. PubMed ID: 2564628 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]